Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) has been given an average rating of “Buy” by the seven ratings firms that are covering the stock, MarketBeat reports. Seven analysts have rated the stock with a buy rating. The average 12 month target price among brokerages that have covered the stock in the last year […]

Related Keywords

United States , Jennifer Michaelson , Stifel Nicolaus , William Blair , Nasdaq , Parkman Healthcare Partners , Securities Exchange Commission , Cullinan Oncology Inc , Affinity Asset Advisors , Franklin Resources Inc , Cullinan Oncology , Get Free Report , Exchange Commission , Asset Advisors , Healthcare Partners , Trexquant Investment , Oncology Stock Down , Get Free , Cullinan Oncology Daily ,